首页|甘露醇联合血栓通、临床干预对胫腓骨骨折早期肿痛的临床疗效观察

甘露醇联合血栓通、临床干预对胫腓骨骨折早期肿痛的临床疗效观察

扫码查看
目的 分析胫腓骨骨折早期肿痛患者采用甘露醇联合血栓通、临床干预的综合效果.方法 湖州市中心医院自2014年6月~2017年1月期间共接收100例胫腓骨骨折早期肿痛患者,分为观察组(50例)和对照组(50例).对照组予以常规甘露醇联合血栓通治疗以及常规护理,在对照组的基础上观察组实施护理干预.对比2组患者的治疗效果以及护理效果.结果 2组总有效率、护理服务满意度以及治疗后的VAS评分的差异均具有统计学意义(P<0.05).结论 甘露醇联合血栓通并同时强化临床护理干预,有助于提高胫腓骨骨折早期肿痛患者的治疗效果,减轻疼痛,值得推广应用.
Clinical observation on the effect of mannitol combined with Xueshuantong on the treatment of early swelling and pain in the patients with tibia and fibula fracture
Objective To summarize and analyze the effect of mannitol combined with Xueshuantong on the treatment of early swelling and pain in patients with tibial and fibula fracture. Methods In Huzhou central hospital from June 2014 to January 2017, 100 cases with early swelling and pain with tibia and fibula fractur were divided into the observation group (50 cases) and the control group (50 cases). The control group were given routine mannitol combined with Xueshuantong treatment and routine nursingcare, at this basis, the observation group were received nursing intervention. The effect of the treatment and nursing in the two groups were compared. Results The total effective rate, nursing service satisfaction and the VAS score after treatment between the two groups were statistically significant (P<0.05). Conclusion The treatment of mannitol combined with Xueshuantong and strengthening clinical nursing intervention is helpful to improve the therapeutic effect and alleviate the pain of the patients with early swelling and pain with tibia and fibula fracture.

tibia and fibula fractureearly swelling and painmannitolXueshuantong

熊培丽

展开 >

湖州市中心医院 骨科,浙江 湖州 313000

胫腓骨骨折 早期肿痛 甘露醇 血栓通

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(9)
  • 2
  • 8